Next Generation Diabetes Therapy and Drug Delivery Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Next Generation Diabetes Therapy and Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Diabetes Therapy and Drug Delivery Overall Market Size
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size: 2021 VS 2027
2.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next Generation Diabetes Therapy and Drug Delivery Players in Global Market
3.2 Top Global Next Generation Diabetes Therapy and Drug Delivery Companies Ranked by Revenue
3.3 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Companies
3.4 Top 3 and Top 5 Next Generation Diabetes Therapy and Drug Delivery Companies in Global Market, by Revenue in 2020
3.5 Global Companies Next Generation Diabetes Therapy and Drug Delivery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Players in Global Market
3.6.1 List of Global Tier 1 Next Generation Diabetes Therapy and Drug Delivery Companies
3.6.2 List of Global Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Market Size Markets, 2021 & 2027
4.1.2 Inhalable Insulin
4.1.3 Oral Insulin
4.1.4 Insulin Patches
4.1.5 CGM Systems
4.1.6 Artificial Pancreas
4.2 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2016-2021
4.2.2 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2022-2027
4.2.3 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Market Size, 2021 & 2027
5.1.2 Diagnostic/Clinics
5.1.3 ICUs
5.1.4 Home Healthcare
5.2 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2016-2021
5.2.2 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2022-2027
5.2.3 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Market Size, 2021 & 2027
6.2 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2016-2021
6.2.2 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2022-2027
6.2.3 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.3.2 US Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.3.3 Canada Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.3.4 Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.4.2 Germany Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.3 France Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.4 U.K. Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.5 Italy Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.6 Russia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.7 Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.4.8 Benelux Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.5.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5.3 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5.4 South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5.5 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.5.6 India Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.6.2 Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.6.3 Argentina Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue, 2016-2027
6.7.2 Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.7.3 Israel Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.7.4 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
6.7.5 UAE Next Generation Diabetes Therapy and Drug Delivery Market Size, 2016-2027
7 Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.1.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.1.5 Johnson & Johnson Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.2.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.2.5 Abbott Laboratories Key News
7.3 Medtronic
7.3.1 Medtronic Corporate Summary
7.3.2 Medtronic Business Overview
7.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.3.5 Medtronic Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.4.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.4.5 Sanofi Key News
7.5 Novo Nordisk
7.5.1 Novo Nordisk Corporate Summary
7.5.2 Novo Nordisk Business Overview
7.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.5.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.5.5 Novo Nordisk Key News
7.6 MannKind Corporation
7.6.1 MannKind Corporation Corporate Summary
7.6.2 MannKind Corporation Business Overview
7.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.6.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.6.5 MannKind Corporation Key News
7.7 Enteris BioPharma
7.7.1 Enteris BioPharma Corporate Summary
7.7.2 Enteris BioPharma Business Overview
7.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.4.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.7.5 Enteris BioPharma Key News
7.8 Dexcom
7.8.1 Dexcom Corporate Summary
7.8.2 Dexcom Business Overview
7.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.8.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.8.5 Dexcom Key News
7.9 Senseonics
7.9.1 Senseonics Corporate Summary
7.9.2 Senseonics Business Overview
7.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.9.4 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.9.5 Senseonics Key News
7.10 Medtech
7.10.1 Medtech Corporate Summary
7.10.2 Medtech Business Overview
7.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.10.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.10.5 Medtech Key News
7.11 Synertech
7.11.1 Synertech Corporate Summary
7.11.2 Synertech Business Overview
7.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.11.4 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.11.5 Synertech Key News
7.12 Zosano Pharma
7.12.1 Zosano Pharma Corporate Summary
7.12.2 Zosano Pharma Business Overview
7.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.12.4 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.12.5 Zosano Pharma Key News
7.13 Relmada Therapeutics
7.13.1 Relmada Therapeutics Corporate Summary
7.13.2 Relmada Therapeutics Business Overview
7.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.13.4 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.13.5 Relmada Therapeutics Key News
7.14 Eli Lilly and Company
7.14.1 Eli Lilly and Company Corporate Summary
7.14.2 Eli Lilly and Company Business Overview
7.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.14.4 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.14.5 Eli Lilly and Company Key News
7.15 Transdermal Specialties
7.15.1 Transdermal Specialties Corporate Summary
7.15.2 Transdermal Specialties Business Overview
7.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
7.15.4 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (2016-2021)
7.15.5 Transdermal Specialties Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Next Generation Diabetes Therapy and Drug Delivery Market Opportunities & Trends in Global Market
Table 2. Next Generation Diabetes Therapy and Drug Delivery Market Drivers in Global Market
Table 3. Next Generation Diabetes Therapy and Drug Delivery Market Restraints in Global Market
Table 4. Key Players of Next Generation Diabetes Therapy and Drug Delivery in Global Market
Table 5. Top Next Generation Diabetes Therapy and Drug Delivery Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Next Generation Diabetes Therapy and Drug Delivery Revenue Share by Companies, 2016-2021
Table 8. Global Companies Next Generation Diabetes Therapy and Drug Delivery Product Type
Table 9. List of Global Tier 1 Next Generation Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Next Generation Diabetes Therapy and Drug Delivery Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2022-2027
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 32. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 35. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 36. Medtronic Corporate Summary
Table 37. Medtronic Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 38. Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 41. Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 42. Novo Nordisk Corporate Summary
Table 43. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 44. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 45. MannKind Corporation Corporate Summary
Table 46. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 47. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 48. Enteris BioPharma Corporate Summary
Table 49. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 50. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 51. Dexcom Corporate Summary
Table 52. Dexcom Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 53. Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 54. Senseonics Corporate Summary
Table 55. Senseonics Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 56. Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 57. Medtech Corporate Summary
Table 58. Medtech Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 59. Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 60. Synertech Corporate Summary
Table 61. Synertech Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 62. Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 63. Zosano Pharma Corporate Summary
Table 64. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 65. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 66. Relmada Therapeutics Corporate Summary
Table 67. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 68. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 69. Eli Lilly and Company Corporate Summary
Table 70. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 71. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
Table 72. Transdermal Specialties Corporate Summary
Table 73. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Product Offerings
Table 74. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Next Generation Diabetes Therapy and Drug Delivery Segment by Type
Figure 2. Next Generation Diabetes Therapy and Drug Delivery Segment by Application
Figure 3. Global Next Generation Diabetes Therapy and Drug Delivery Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Next Generation Diabetes Therapy and Drug Delivery Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2020
Figure 8. By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
Figure 9. By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
Figure 10. By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
Figure 11. By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
Figure 12. US Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
Figure 16. Germany Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 17. France Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
Figure 24. China Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 28. India Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
Figure 30. Brazil Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2016-2027
Figure 33. Turkey Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Next Generation Diabetes Therapy and Drug Delivery Revenue, (US$, Mn), 2016-2027
Figure 37. Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Johnson & Johnson
Abbott Laboratories
Medtronic
Sanofi
Novo Nordisk
MannKind Corporation
Enteris BioPharma
Dexcom
Senseonics
Medtech
Synertech
Zosano Pharma
Relmada Therapeutics
Eli Lilly and Company
Transdermal Specialties